发明名称 Heterocyclic compounds as JAK receptor and protein tyrosine kinase inhibitors
摘要 The invention relates to compounds of general formula (I) wherein A, R1, R2, R3, R4, R5, R9, m and n are defined as defined herein, and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use—alone or in combination with one or more other pharmaceutically active compounds—in therapy, as JAK kinase and protein tyrosine kinase inhibitors for preventing, treating or ameliorating diseases and complications thereof, including, for example, psoriasis, atopic dermatitis, rosacea, lupus, multiple sclerosis, rheumatoid arthritis, Type I diabetes, asthma, cancer, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukaemia, eye diseases such as diabetic retinopathy and macular degeneration as well as other autoimmune diseases and indications where immunosuppression would be desirable for example in organ transplantation.;
申请公布号 US9346809(B2) 申请公布日期 2016.05.24
申请号 US201013382665 申请日期 2010.07.08
申请人 LEO PHARMA A/S 发明人 Nielsen Simon Feldbæk;Greve Daniel Rodriguez;Ryttersgaard Carsten;Grue-Sørensen Gunnar;Ottosen Erik Rytter;Poulsen Tina Dahlerup;Schou Søren Christian;Murray Anthony
分类号 C07D487/04;C07D519/00;A61K31/519;C07D471/04;A61P37/00;A61P19/02;A61P25/28;A61P35/00;A61P11/06;A61P3/10;A61P17/06;A61P17/14;A61P17/10;A61P17/00;A61P17/08;A61P17/04;A61P19/06;A61P11/00 主分类号 C07D487/04
代理机构 Birch, Stewart, Kolasch & Birch, LLP 代理人 Birch, Stewart, Kolasch & Birch, LLP
主权项 1. A compound of general formula Iwherein m is 0-3; n is 2, 4, 6, or 8; A is N; R2 is hydrogen; R1 and R9 independently are selected from the group consisting of hydrogen, halogen, cyano, —NH2, —SO2NH2, —SONH2, and —CONH2; or R1 and R9 independently are selected from the group consisting of alkyl-, alkenyl-, alkynyl-, alkenylalkyl-, alkynylalkyl-, cycloalkyl-, cycloalkenyl-, cycloalkylalkyl-, cycloalkylalkenyl-, cycloalkylalkynyl-, cycloalkenylalkyl-, cycloalkenylalkenyl-, cycloalkenylalkynyl-, heterocyclyl-, heterocyclylalkyl-, heterocyclylalkenyl-, heterocyclylalkynyl-, R1aO-L-, R1aS-L, (R1a)2N-L-, R1b—C(═O)-L-, R1bO—C(═O)-L, (R1b)2N—C(═O)-L-, R1b—C(═O)N(R1c)-L-, R1bO—C(═O)N(R1c)-L-, (R1b)2N—C(═O)N(R1c)-L-, R1b—C(═O)O-L-, R1bO—C(═O)O-L-, (R1b)2N—C(═O)O-L-, R1b—S(═O)-L-, R1b—S(═O)2-L-, R1bO—S(═O)-L-, R1bO—S(═O)2-L-, (R1b)2N—S(═O)-L-, (R1b)2N—S(═O)2-L-, R1b—S(═O)N(R1c)-L-, R1b—S(═O)2N(R1c)-L-, R1bO—S(═O)N(R1c)-L-, R1bO—S(═O)2N(R1c)-L-, (R1b)2N—S(═O)2N(R10)-L-, R1b—S(═O)O-L-, R1b—S(═O)2O-L-, R1bO—S(═O)O-L-, R1bO—S(═O)2O-L-, (R1b)2N—S(═O)O-L-, (R1b)2N—S(═O)2O-L-, aryl-, arylalkyl-, arylalkenyl-, arylalkynyl-, arylcycloalkyl-, aryloxy-, aryloxyalkyl-, aryloxycycloalkyl-, heteroaryl-, heteroarylalkyl-, heteroarylalkenyl-, heteroarylalkynyl, heteroarylcycloalkyl-, heteroaryloxy-, heteroaryloxyalkyl-, and heteroaryloxycycloalkyl-, either of which may be optionally substituted with one or more R1d; L is a covalent bond or L is independently at each occurrence selected from the group consisting of alkyl-, cycloalkyl-, alkylcycloalkyl- and cycloalkylalkyl-; R1a is hydrogen; or R1a independently at each occurrence is selected from the group consisting of alkyl-, alkenyl-, alkynyl-, cycloalkyl, -heterocyclyl-, aryl- and heteroaryl-, either of which may be optionally substituted with one or more R1e; or in the case where two R1as are attached to the same N, they may together with the N atom to which they are attached form a heterocycle which may be optionally substituted with one or more R1e; R1b and R1c independently at each occurrence are selected from the group consisting of alkyl-, alkenyl-, alkynyl-, cycloalkyl-, cycloalkenyl-, cycloalkylalkyl-, cycloalkylalkenyl-, cycloalkylalkynyl-, cycloalkenylalkyl-, cycloalkenylalkenyl-, cycloalkenylalkynyl-, heterocyclyl-, heterocyclylalkyl-, heterocyclylalkenyl-, heterocyclylalkynyl-, aryl-, arylalkyl-, arylalkenyl-, arylalkynyl-, arylcycloalkyl-, aryloxyalkyl-, aryloxycycloalkyl-, heteroaryl-, heteroarylalkyl-, heteroarylalkenyl-, heteroarylalkynyl-, heteroarylcycloalkyl, heteroaryloxyalkyl-, and heteroaryloxycycloalkyl-, either of which may be optionally substituted with one or more R1e; or in the case where two R1bs or two R1cs are attached to the same N, they may together with the N atom to which they are attached form a heterocycle which may be optionally substituted with one or more R1e; R1d and R1e independently at each occurrence are selected from the group consisting of halogen, cyano, hydroxy, oxo, —NH2, —SO2NH2, —SONH2, —CONH2, alkyl-, alkenyl-, alkynyl-, cycloalkyl-, cycloalkenyl-, heterocyclyl-, R1fO-L-, R1fS-L-, (R1f)2N-L-, R1fO—R1fO-L-, R1f—C(═O)-L-, R1fO—C(═O)-L-, (R1f)2N—C(═O)-L-, R1f—C(═O)N(R1f)-L-, R1fO—C(═O)N(R1f)-L-, (R1f)2N—C(═O)N(R1f)-L-, R1f—C(═O)O-L-, R1fO—C(═O)O-L-, (R1f)2N—C(═O)O-L-, R1fO—S(═O)2-L-, (R1f)2N—S(═O)2-L-, R1f—S(═O)2N(R1f)-L-, R1fO—S(═O)2N(R1f)-L-, (R1f)2N—S(═O)2N(R1f)-L-, R1f—S(═O)2O-L-, R1fO—S(═O)2O-L-, (R1f)2N—S(═O)2O-L-, aryl-, aryloxy-, heteroaryl-, and heteroaryloxy-; R1f independently at each occurrence is selected from the group consisting of alkyl-, alkenyl-, alkynyl-, cycloalkyl-, heterocyclyl-, aryl- and heteroaryl-; R3 is independently at each occurrence a covalent bond or alkyl- or heteroalkyl-, which may be optionally substituted with one or more R3a, wherein any two R3s form, together with the ring atom(s) to which they are attached, a cycloalkyl or heterocycle, with the proviso that said two R3s are either attached to the same C atom or to two non-adjacent C atoms; R3a independently at each occurrence is selected from the group consisting of halogen, cyano, hydroxy, oxo, —NH2, —SO2NH2, —SONH2, —CONH2, alkyl-, alkenyl-, alkynyl-, alkenylalkyl-, alkynylalkyl-, cycloalkyl-, cycloalkenyl-, cycloalkylalkyl-, cycloalkylalkenyl-, cycloalkylalkynyl-, cycloalkenylalkyl-, cycloalkenylalkenyl-, cycloalkenylalkynyl-, heterocyclyl-, heterocyclylalkyl-, heterocyclylalkenyl-, heterocyclylalkynyl-, R3bO-L-, R3bS-L-, (R3b)2N-L-, R3b—C(═O)-L-, R3bO—C(═O)-L-, (R3b)2N—C(═O)-L-, R3b—C(═O)N(R3c)-L-, R3bO—C(═O)N(R3c)-L-, (R3b)2N—C(═O)N(R3c)-L-, R3b—C(═O)O-L-, R3bO—C(═O)O-L-, (R3b)2N—C(═O)O-L-, R3b—S(═O)-L-, R3b—S(═O)2-L-, R3bO—S(═O)-L-, R3bO—S(═O)2-L-, (R3b)2N—S(═O)-L-, (R3b)2N—S(═O)2-L-, R3b—S(═O)N(R3c)-L-, R3b—S(═O)2N(R3c)-L-, R3bO—S(═O)N(R3c)-L-, R3bO—S(═O)2N(R3c)-L-, (R3b)2N—S(═O)2N(R3c)-L-, R3b—S(═O)O-L-, R3b—S(═O)2O-L-, R3bO—S(═O)O-L-, R3bO—S(═O)2O-L-, (R3b)2N—S(═O)O-L-, (R3b)2N—S(═O)2O-L-, aryl-, arylalkyl-, arylalkenyl-, arylalkynyl-, arylcycloalkyl-, aryloxy-, aryloxyalkyl-, aryloxycycloalkyl-, heteroaryl-, heteroarylalkyl-, heteroarylalkenyl-, heteroarylalkynyl-, heteroarylcycloalkyl, heteroaryloxy-, heteroaryloxyalkyl-, and heteroaryloxycycloalkyl-; R3b and R3c independently at each occurrence are selected from the group consisting of hydrogen, alkyl-, alkenyl-, alkynyl-, cycloalkyl-, heterocyclyl-, aryl- and heteroaryl-; R5 independently at each occurrence is selected from the group consisting of halogen, cyano, hydroxy, oxo, —NH2, —SO2NH2, —SONH2, —CONH2, alkyl-, alkenyl-, alkynyl-, alkenylalkyl-, alkynylalkyl-, cycloalkyl-, cycloalkenyl-, cycloalkylalkyl-, cycloalkylalkenyl-, cycloalkylalkynyl-, cycloalkenylalkyl-, cycloalkenylalkenyl-, cycloalkenylalkynyl-, heterocyclyl-, heterocyclylalkyl-, heterocyclylalkenyl-, heterocyclylalkynyl-, R5aO-L-, R5aS-L-, (R5a)2N-L-, R5a—C(═O)-L-, R5aO—C(═O)-L-, (R5a)2N—C(═O)-L-, R5a—C(═O)N(R5b)-L-, R5aO—C(═O)N(R5b)-L-, (R5a)2N—C(═O)N(R5b)-L-, R5a—C(═O)O-L-, R5aO—C(═O)O-L-, (R5a)2N—C(═O)O-L-, R5a—S(═O)-L-, R5a—S(═O)2-L-, R5aO—S(═O)-L-, R5aO—S(═O)2-L-, (R5a)2N—S(═O)-L-, (R5a)2N—S(═O)2-L-, R5a—S(═O)N(R5b)-L-, R5a—S(═O)2N(R5b)-L-, R5aO—S(═O)N(R5b)-L-, R5aO—S(═O)2N(R5b)-L-, (R5a)2N—S(═O)2N(R5b)-L-, R5a—S(═O)O-L-, R5a—S(═O)2O-L-, R5aO—S(═O)O-L-, R5aO—S(═O)2O-L-, (R5a)2N—S(═O)O-L-, (R5a)2N—S(═O)2O-L-, aryl-, arylalkyl-, arylalkenyl-, arylalkynyl-, arylcycloalkyl-, aryloxy-, aryloxyalkyl-, aryloxycycloalkyl-, heteroaryl-, heteroarylalkyl-, heteroarylalkenyl-, heteroarylalkynyl-, heteroarylcycloalkyl, heteroaryloxy-, heteroaryloxyalkyl-, and heteroaryloxycycloalkyl-; R5a and R5b independently at each occurrence are selected from the group consisting of hydrogen, alkyl-, alkenyl-, alkynyl-, cycloalkyl-, heterocyclyl-, aryl- and heteroaryl-; R4 is selected from the group consisting ofwherein X is O or S; Y is O or N—R7; Z is C1-6-alkylene, C2-6-alkenylene, or C2-6-alkynylene, either of which may be optionally substituted with one or more R8; G1 is selected from the group consisting of cycloalkyl-, cycloalkenyl-, heterocyclyl-, aryl- and heteroaryl-, either of which may be optionally substituted with one or more RG; G2 is selected from the group consisting of alkyl-, alkenyl-, alkynyl-, RG2aO-L-, RG2aS-L-, (RG2a)2N-L-, RG2a—C(═O)-L-, RG2aO—C(═O)-L-, (RG2a)2N—C(═O)-L-, RG2a—C(═O)N(RG2b)-L-, RG2aO—C(═O)N(RG2b)-L-, (RG2a)2N—C(═O)N(RG2b)-L-, RG2a—C(═O)O-L-, RG2aO—C(═O)O-L-, (RG2a)2N—C(═O)O-L-, RG2a—S(═O)-L-, RG2a—S(═O)2-L-, RG2aO—S(═O)-L-, RG2aO—S(═O)2-L-, (RG2a)2N—S(═O)-L-, (RG2a)2N—S(═O)2-L-, RG2a—S(═O)N(RG2b)-L-, RG2a—S(═O)2N(RG2b)-L-, RG2aO—S(═O)N(RG2b)-L-, RG2aO—S(═O)2N(RG2b)-L-, (RG2a)2N—S(═O)2N(RG2b)-L-, RG2a—S(═O)O-L-, RG2a—S(═O)2O-L-, RG2aO—S(═O)O-L-, RG2a—S(═O)2O-L-, (RG2a)2N—S(═O)O-L-, and (RG2a)2N—S(═O)2O-L-; either of which may be optionally substituted with one or more RG; RG2a and RG2b independently at each occurrence are selected from the group consisting of hydrogen, alkyl-, alkenyl-, alkynyl-, cycloalkyl-, heterocyclyl-, aryl- and heteroaryl-; RG is selected from the group consisting of halogen, cyano, hydroxy, oxo, —NH2, —SO2NH2, —SONH2, —CONH2, alkyl- and cycloalkyl-, wherein said alkyl- or cycloalkyl- is optionally substituted by one or more substituents selected from the group consisting of halogen, cyano, hydroxy, trifluoromethyl and —NH2; or RG is selected from the group consisting of alkenyl-, alkynyl-, alkenylalkyl-, alkynylalkyl-, cycloalkenyl-, cycloalkylalkyl-, cycloalkylalkenyl-, cycloalkylalkynyl-, cycloalkenylalkyl-, cycloalkenylalkenyl-, cycloalkenylalkynyl-, heterocyclyl-, heterocyclylalkyl-, heterocyclylalkenyl-, heterocyclylalkynyl-, RGaO-L-, RGaS-L-, (RGa)2N-L-, RGa—C(═O)-L-, RGaO—C(═O)-L-, (RGa)2N—C(═O)-L-, RGa—C(═O)N(RGb)-L-, RGaO—C(═O)N(RGO-L-, (RGa)2N—C(═O)N(RGb)-L-, RGa—C(═O)O-L-, RGaO—C(═O)O-L-, (RGa)2N—C(═O)O-L-, RGa—S(═O)-L-, RGa—S(═O)2-L-, RGaO—S(═O)-L-, RGaO—S(═O)2-L-, (RGa)2N—S(═O)-L-, (RGa)2N—S(═O)2-L-, RGb—C(═O)—(RGa)N—(RGa)2N—S(═O)2-L, RGbO—C(═O)—(RGa)N—(RGa)2N—S(═O)2-L, RGa—S(═O)N(RGb)-L-, RGa—S(═O)2N(RGb)-L-, RGaO—S(═O)N(RGb)-L-, RGaO—S(═O)2N(RGb)-L-, (RGa)2N—S(═O)2N(RGb)-L-, RGa—S(═O)O-L-, RGa—S(═O)2O-L-, RGaO—S(═O)O-L-, RGaO—S(═O)2O-L-, (RGa)2N—S(═O)O-L-, (RGa)2N—S(═O)2O-L-, aryl-, arylalkyl-, arylalkenyl-, arylalkynyl-, arylcycloalkyl-, aryloxy-, aryloxyalkyl-, aryloxycycloalkyl-, heteroaryl-, heteroarylalkyl-, heteroarylalkenyl-, heteroarylalkynyl-, heteroarylcycloalkyl, heteroaryloxy-, heteroaryloxyalkyl-, and heteroaryloxycycloalkyl-; RGa and RGb independently at each occurrence are selected from the group consisting of hydrogen, alkyl-, alkenyl-, alkynyl-, cycloalkyl-, heterocyclyl-, heterocyclylalkyl, aryl-, heteroaryl- and heteroarylalkyl; wherein said alkyl-, alkenyl-, alkynyl-, cycloalkyl-, heterocyclyl-, heterocyclylalkyl, aryl-, heteroaryl- or heteroarylalkyl group is optionally substituted one or more times by a substituent selected from the group consisting of halogen, cyano, hydroxy, methyl, trifluoromethyl, methoxy and —NH2; R7 is hydrogen or is independently at each occurrence selected from the group consisting of alkyl-, alkenyl-, alkynyl-, cycloalkyl-, heterocyclyl-, aryl- and heteroaryl-, either of which may be optionally substituted with one or more R7a; R7a independently at each occurrence is selected from the group consisting of halogen, cyano, hydroxy, oxo, —NH2, —SO2NH2, —SONH2, —CONH2, alkyl-, alkenyl-, alkynyl-, cycloalkyl-, heterocyclyl-, aryl- and heteroaryl-; R8 independently at each occurrence is selected from the group consisting of hydrogen, halogen, cyano, hydroxy, oxo, —NH2, —SO2NH2, —SONH2, —CONH2, alkyl- and cycloalkyl, wherein said alkyl- or cycloalkyl- is optionally substituted by one or more substituents selected from the group consisting of halogen, cyano, hydroxy, trifluoromethyl and —NH2; or two R8s may, together with the C atom(s) to which they are attached, form an optionally substituted cycloalkyl or heterocycle;and pharmaceutically acceptable salts, hydrates, or solvates thereof.
地址 Ballerup DK
您可能感兴趣的专利